Clinical trial
Exploratory Study of Pagoclone in Men With Premature Ejaculation.
NCT00370981 · Endo Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00370981 |
|---|---|
| Title | Exploratory Study of Pagoclone in Men With Premature Ejaculation. |
| Official title | A Four-arm, Randomized, Double-blind, Parallel, Placebo-controlled Exploratory Study of Pagoclone 0.15mg, 0.30mg, and 0.60mg in Men With Primary Premature Ejaculation. |
| Lead sponsor | Endo Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Premature Ejaculation |
| Intervention type | Drug |
| Interventions | pagoclone |
| Enrollment | 100 |
| Start date | Jul 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 1, 2006 |
| Last update posted | Dec 27, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: